Patients with cancer detected on screening mammography undergo less toxic treatment

December 27, 2004

Women who have their breast cancers detected by physical examinations are at least twice as likely to undergo toxic treatments than those who have their cancer detected by mammography--regardless of the age of the woman, a new study shows.

The study reviewed 992 women with invasive breast cancer--460 of them had their cancer detected on screening mammography and 532 on physical examination, said the lead author of the study, Richard J. Barth, Jr., MD, Chief of the Division of Surgical Oncology at Dartmouth-Hitchcock Medical Center.

Overall, patients whose cancer was detected at physical examination were three times more likely to be treated with chemotherapy than those who had their cancer detected by screening mammography, said Dr. Barth. Women in the 40-49 age group were about two times more likely and women in the 70 and older age group were about five times more likely to undergo chemotherapy if their cancer was detected by physical examination, Dr. Barth said.

Chemotherapy is commonly recommended for patients with tumors larger than 1 cm in diameter or with cancer that has spread into the lymph nodes, he said. Cancers detected by mammography were half as large as those detected by physical exam. In addition, only 16% of those patients whose tumors were detected by mammography had cancer spread to the lymph nodes compared with 42% of those who had their breast cancer detected on physical examination, he said.

Overall, patients who had their breast cancer detected on physical examination were more than twice as likely to be treated with mastectomy rather than breast conservation, Dr. Barth added. Women in the 70 and older age group were about five times more likely to have a mastectomy if their cancer was detected by physical examination rather than mammography. Women in the younger age group were also more likely to have a mastectomy if they had their cancer detected by physical examination, Dr. Barth said.

While there continues to be debate on whether screening mammography increases survival of women ages 40-49 and 70 and older, there is no doubt that mammography detects cancer earlier, Dr. Barth said. This study emphasizes that screening mammography allows patients who are unfortunate enough to develop breast cancer to be treated with less-toxic therapy, regardless of their age. It provides strong supporting evidence that women over 40 should be screened with mammography, he said.
-end-
The study appears in the January 2005 issue of the American Journal of Roentgenology.

A PDF of the study is available upon request to reporters.

American College of Radiology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.